# bib

id: jrenhep-9
author: Halldorson, Jeffrey
title: Welcome to the Journal of Renal and Hepatic Disorders
date: 2017-02-03
pages: 2
extension: .pdf
mime: application/pdf
words: 1130
sentence: 81
flesch: 47
cache: cache/jrenhep-9.pdf
txt: txt/jrenhep-9.txt
summary:
  A common and well-known example of this interac- tion is the hepatorenal syndrome in end-stage cirrhosis of the liver in which the vasogenic effects of liver disease initially result in acute kidney injury but may progress to irreversible ischemic renal failure if the vasogenic influence of liver failure is not reversed quickly enough (1–3). The emerging pathophysiology of fatty liver disease is a growing topic (9).


id: jrenhep-8
author: Testino, Gianni; Leone, Silvia
title: Alcoholic Hepatitis and Liver Transplantation
date: 2017-02-03
pages: 2
extension: .pdf
mime: application/pdf
words: 1541
sentence: 112
flesch: 47
cache: cache/jrenhep-8.pdf
txt: txt/jrenhep-8.txt
summary:
  Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center. Data from the literature have stated for a long time that the approach to patients with alcoholic liver disease (ALD) should be changed with no ethical or technical precon- ceptions.


id: jrenhep-104
title: Gabapentin Toxicity and Role of Dialysis; Case Series and Literature Review
date: 2021-12-14
pages: 3
extension: .pdf
mime: application/pdf
words: 2002
sentence: 144
flesch: 58
cache: cache/jrenhep-104.pdf
txt: txt/jrenhep-104.txt
author:
  Latief, Muzamil; Bhat, Mohd Iqbal; Wani, Mohd Latief; Shafi, Obeid; Goud, L. Naresh; Abbas, Farhat; Wani, Mohsin

summary:
  Most of the published literature on gabapentin toxicity in CKD are case studies (3,4). In cases reported with gabapentin toxicity, patients had varying manifestations including tremors, altered mental status, and respiratory depression requiring intubation (5).


id: jrenhep-34
author: Agrawal, Nikhil; Agrawal, Sahil; Tripathi, Nishita; Segal, Mark
title: Potassium Profiling in Hemodialysis
date: 2018-08-07
pages: 4
extension: .pdf
mime: application/pdf
words: 2628
sentence: 192
flesch: 50
cache: cache/jrenhep-34.pdf
txt: txt/jrenhep-34.txt
summary:
  We provide a review of studies that compare constant potassium concentration in dialysate to gradual reduction in dialysate potassium concentration. In a large international cohort of HD patients, dialysate potassium concentration varied among clinical practices and countries and ranged anywhere from 1 meq/L to 3 meq/L (28).


id: jrenhep-20
author: Card, Mary Elizabeth; Moeckel, Gilbert; Turner, Jeffrey M.
date: 2017-07-20
pages: 4
extension: .pdf
mime: application/pdf
words: 3293
sentence: 233
flesch: 48
cache: cache/jrenhep-20.pdf
txt: txt/jrenhep-20.txt
title:
  Renal Recovery Following Orthotopic Liver Transplant after Prolonged Kidney Injury: Perspectives on Diagnosing Hepatorenal Syndrome and Determining Which Patients Should Undergo Simultaneous Liver–Kidney Transplantation

summary:
  2. Johnson R, Couser W. Hepatitis B infection and renal disease: Clinical, immunopathogenic and therapeutic considerations. Kidney Int. Our understanding of why some patients with HRS recover renal function after OLT and why others do not is limited; however, some data suggest that duration of kidney injury prior to transplant is an important factor (5).


id: jrenhep-33
author: Lioufas, Nicole; Street, Alan; de Crespigny, Paul Champion; G. Holt, Stephen
date: 2018-06-29
pages: 5
extension: .pdf
mime: application/pdf
words: 3359
sentence: 196
flesch: 48
cache: cache/jrenhep-33.pdf
txt: txt/jrenhep-33.txt
title:
  Monitoring the Effects of Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Switch for Tubulotoxicity in Highly Treatment-Experienced or in Very Sick Individuals Infected with HIV

summary:
  Utility of uAPR measurement in HIV infection. HIV infection: Epidemi- ology, pathogenesis, treatment, and prevention.


id: jrenhep-2
author: Pothugunta, Krishna; Voora, Santhi; Kramer, Holly Joy; Bidani, Anil K.; Vellanki, Kavitha
title: Outcomes of Albumin Use in the Treatment of Acute Hepatorenal Disorders: A Single Center Experience
date: 2017-02-03
pages: 6
extension: .pdf
mime: application/pdf
words: 3756
sentence: 213
flesch: 48
cache: cache/jrenhep-2.pdf
txt: txt/jrenhep-2.txt
summary:
  Earlier studies have reported cases of increasing pleural effusions, development of pulmonary edema, and heart failure and rupture of esopha- geal varices with albumin infusions in cirrhotic patients (12). A lag period between albumin infusions and CXR findings and/or symptoms of pulmonary edema could be a major confounder when trying to determine a cor- relation between the amount of albumin infused and the development of pulmonary edema.


id: jrenhep-12
author: Chan, Samuel; Au, Kenneth; Francis, Ross; Mudge, David W.; Johnson, David W.; Rahman, Tony
title: An Update on Hepatorenal Syndrome
date: 2017-03-22
pages: 7
extension: .pdf
mime: application/pdf
words: 3893
sentence: 241
flesch: 43
cache: cache/jrenhep-12.pdf
txt: txt/jrenhep-12.txt
summary:
  Simultaneous liver–kidney transplantation is not necessary for patients with isolated HRS and should only be considered in selected patients at high risk for non-recov- ery of renal function, such as patients with heavy proteinuria and other evidence of advanced primary renal disease. JRENHEP012 - Copy 55..61 jrenhep.com codonpublications.com REVIEW ARTICLE An Update on Hepatorenal Syndrome Samuel Chan 1,2 , Kenneth Au 2,3 , Ross Francis 1 , David W. Mudge 1 , David W. Johnson 1 , Tony Rahman 3 1Department of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia; 2Centre for Health Services Research, University of Queensland, Brisbane, Queensland, Australia; 3Department of Gastroenterology and Hepatology, The Prince Charles Hospital, Chermside, Queensland, Australia Abstract Hepatorenal syndrome (HRS) is one of the many potential causes of acute kidney injury (AKI) in patients with decompensated liver disease.


id: jrenhep-3
date: 2017-02-03
pages: 6
extension: .pdf
mime: application/pdf
words: 4297
sentence: 298
flesch: 53
cache: cache/jrenhep-3.pdf
txt: txt/jrenhep-3.txt
author:
  Campos, Andreia; Santos, Josefina; Freitas, Cristina; Castro, Ana; Santos, Sofia; Pedro Pimentel, Joa ̃o; Cabrita, Antonio

title:
  Plasmapheresis in the Management of Acute Pancreatitis due to Severe Hypertriglyceridemia—Reporting New Cases

summary:
  PF was done according to TG levels. It is generally believed that TG levels of >1000 mg/dl are a greater risk factor for AP (3).


id: jrenhep-11
author: Coppolino, Giuseppe; Cernaro, Valeria; Rivoli, Laura; Pinciaroli, Angela; Bolignano, Davide
title: Renal Concerns in the Treatment of Chronic Hepatitis B with Tenofovir
date: 2017-03-23
pages: 5
extension: .pdf
mime: application/pdf
words: 4304
sentence: 314
flesch: 44
cache: cache/jrenhep-11.pdf
txt: txt/jrenhep-11.txt
summary:
  Screening of risk factors for renal disease before starting TDF therapy and a careful mon- itoring of sCr, eGFR, serum phosphate and urine analysis during treatment are important mainstays for guiding the pre- scription of this drug and to promptly reduce dosage or inter- rupt therapy if nephrotoxicity occurs. Dose adjustment of TDF and early diagnosis of TDF-related renal damage The American Association for the Study of Liver Diseases (AASLD) guidelines recommend to measure eGFR, phospha- turia, urine protein/creatinine ratio, glycosuria and tubular proteinuria in patients with HIV infection every 6 months during TDF therapy.


id: jrenhep-15
author: Rech, Megan A.; Von Roenn, Natasha; Durazo-Arvizu, Ramon; Cotler, Scott J.; Kramer, Holly
title: Vitamin D Levels Are Associated with Liver Disease Severityin Patients with Cirrhosis
date: 2017-05-26
pages: 9
extension: .pdf
mime: application/pdf
words: 5038
sentence: 326
flesch: 52
cache: cache/jrenhep-15.pdf
txt: txt/jrenhep-15.txt
summary:
  Rech MA et al. Journal of Renal and Hepatic Disorders 2017; 1(2): 1–9 4 were selected because they may influence vitamin D levels (2, 6). A comparison of measured and calculated free 25(OH) vitamin D levels in clinical populations.


id: jrenhep-58
author: Fradelos, Evangelos C.
date: 2020-05-07
pages: 9
extension: .pdf
mime: application/pdf
words: 5161
sentence: 274
flesch: 57
cache: cache/jrenhep-58.pdf
txt: txt/jrenhep-58.txt
title:
  The Effect of Clinical and Demographic Factors on Quality of Life in End-Stage Renal Disease. A Multicenter Cross-Sectional Study

summary:
  <0.001 Educational status Primary education (1) 3.14 ± 0.94 2.92 ± 11.65 5.68 ± 10.17 10.86 ± 13.50 High school (2) 3.59 ± 0.86 4.79 ± 8.89 6.91 ± 10.19 12.83 ± 12.29 University (3) 3.59 ± 0.94 6.71 ± 7.57 7.86 ± 12.22 13.89 ± 13.29 (Continued) Quality of life in hemodialysis Journal of Renal and Hepatic Disorders 2020; 4(1): 1–9 5 Table 1. Yes −8.86 ± 13.23 3.02 ± 13.82 16.21 ± 3.77 No −6.04 ± 13.38 6.48 ± 14.99 17.53 ± 3.83 t 1.713 1.905 2.791 p 0.087 0.058 0.006 Educational status Primary education (1) −6.74 ± 12.69 1.44 ± 14.97 16.42 ± 4.06 High school (2) −7.15 ± 14.34 8.44 ± 14.50 17.58 ± 3.62 University (3) −5.48 ± 12.50 8.32 ± 12.85 18.13 ± 3.66 (Continued) Quality of life in hemodialysis Journal of Renal and Hepatic Disorders 2020; 4(1): 1–9 7 Table 2 .


id: jrenhep-52
title: Cholemic Nephropathy: Hyperbilirubinemia and its Impact on Renal Function
date: 2019-03-18
pages: 7
extension: .pdf
mime: application/pdf
words: 5201
sentence: 334
flesch: 46
cache: cache/jrenhep-52.pdf
txt: txt/jrenhep-52.txt
author:
  Chávez-Iñiguez, Jonathan S.; Meza-Ríos, Alejandra; Santos-Garcia, Arturo; García-García, Guillermo; Armendariz-Borunda, Juan

summary:
  AKI in cirrhosis patients in the context of hyperbilirubinemia AKI that occurs in patients with cirrhosis due to severe hy- poperfusion and impairment in the systemic arterial circula- tion has been known as hepatorenal syndrome (HRS) (10). Odell et al.


id: jrenhep-49
title: The Role of Stearoyl-coenzyme A Desaturase 1 in Liver Development, Function, and Pathogenesis
date: 2019-02-06
pages: 8
extension: .pdf
mime: application/pdf
words: 5496
sentence: 422
flesch: 44
cache: cache/jrenhep-49.pdf
txt: txt/jrenhep-49.txt
author:
  Mohammadzadeh, Fatemeh; Hosseini, Vahid; Alihemmati, Alireza; Shaaker, Maghsod; Mosayyebi, Gholamali; Darabi, Masoud; Mehdizadeh, Amir

summary:
  Thiazole-4-acetic acid derivative Another potent liver-selective SCD1 inhibitor, compound 48 (a thiazole-4-acetic acid derivative), has recently been discovered through high-throughput screening efforts fol- lowing an ex vivo assay approach on mice liver and eyelids (55). SCD1 may play a key role in liver development and hepatic lipid homeostasis through promoting monounsaturated protein acylation and converting lipotoxic saturated fatty acids into monounsaturated fatty acids.


id: jrenhep-56
author: Gonzaga, Ernesto Robalino; Andrew, Austin; Jan George, Freeman
title: Wasting Away with Cirrhosis: A Review of Hepatic Sarcopenia
date: 2019-09-09
pages: 7
extension: .pdf
mime: application/pdf
words: 5609
sentence: 428
flesch: 48
cache: cache/jrenhep-56.pdf
txt: txt/jrenhep-56.txt
summary:
  The homeostasis of muscle bulk is tightly regulated requir- ing a balance between muscle protein synthesis and muscle proteolysis. Muscle protein synthesis and muscle satellite cell recruitment are important factors in maintaining muscle bulk.


id: jrenhep-6
author: Mehdizadeh, Amir; Darabi, Masoud
title: Reprogrammed Cell‐based Therapy for Liver Disease: From Labto Clinic
date: 2017-02-03
pages: 9
extension: .pdf
mime: application/pdf
words: 6465
sentence: 545
flesch: 45
cache: cache/jrenhep-6.pdf
txt: txt/jrenhep-6.txt
summary:
  Here, we introduce main practical strategies for redifferentiation of pluripotent cells to liver cells. An average 20% repopulation of liver cells was recorded.


id: jrenhep-37
title: Imaging of Renal Angiomyolipomatosis
date: 2018-11-14
pages: 10
extension: .pdf
mime: application/pdf
words: 6522
sentence: 593
flesch: 51
cache: cache/jrenhep-37.pdf
txt: txt/jrenhep-37.txt
author:
  Greco, Federico; Augusto Mallio, Carlo; Cirimele, Vincenzo; D’Alessio, Pasquale; Beomonte Zobel, Bruno; Francesco Grasso, Rosario

summary:
  Update on the diagnosis and management of renal angiomyolipoma. Changing trends in presentation, diagnosis and management of renal angiomyolipoma: Comparison of sporadic and tuberous sclerosis complex-associated forms.


id: jrenhep-5
title: Anaemia of Chronic Kidney Disease: What We Know Now
date: 2017-02-03
pages: 9
extension: .pdf
mime: application/pdf
words: 7260
sentence: 585
flesch: 46
cache: cache/jrenhep-5.pdf
txt: txt/jrenhep-5.txt
author:
  Krishnan, Anoushka R.; Trinder, Debbie; G. Chua, Anita C.; Chakera, Aron; Ramm, Grant A.; Olynyk, John K.

summary:
  The improvement in haemo- globin resulted from increased serum iron levels and better haemoglobinisation of erythroid precursors, without affecting inflammatory responses in these mice. Issues with iron therapy With regard to iron administration during episodes of acute infection or inflammation which results in elevated serum ferritin levels, opinions suggest that iron therapy should be withheld under such circumstances, citing a concern that iron may further help in the proliferation of microorganisms.


id: jrenhep-47
author: Bolik, Julia; Tirnitz-Parker, Janina E. E.; Schmidt-Arras, Dirk
title: ADAM and ADAMTS Proteases in Hepatic Disorders
date: 2019-02-07
pages: 10
extension: .pdf
mime: application/pdf
words: 7377
sentence: 556
flesch: 50
cache: cache/jrenhep-47.pdf
txt: txt/jrenhep-47.txt
summary:
  The role of liver progenitor cells during liver regeneration, fibrogenesis, and carcinogenesis. Role of TWEAK in coregulating liver progenitor cell and fibrogenic responses.


id: jrenhep-18
author: Salvadori, Maurizio; Tsalouchos, Aris
title: Liver Transplantation for Monogenic Metabolic Diseases Involvingthe Kidney
date: 2017-07-19
pages: 12
extension: .pdf
mime: application/pdf
words: 8797
sentence: 762
flesch: 51
cache: cache/jrenhep-18.pdf
txt: txt/jrenhep-18.txt
summary:
  Liver or combined liver-kidney transplantation Journal of Renal and Hepatic Disorders 2017; 1(2): 29–40 35 Alpha1-antitrypsin deficiency The most common genetic cause of liver disease in children is AATD (102), an autosomal recessive disorder caused by mutations in the SERPINA 1 gene (103). Liver disease develops in children with PiZZ mutation.


id: jrenhep-43
author: Salvadori, Maurizio; Tsalouchos, Aris
title: Hepatitis C Virus Infection and Renal Disorders
date: 2019-01-16
pages: 14
extension: .pdf
mime: application/pdf
words: 10185
sentence: 837
flesch: 49
cache: cache/jrenhep-43.pdf
txt: txt/jrenhep-43.txt
summary:
  Both recurrent and de novo GN have been observed in HCV renal transplant patients. Overall, the prevalence of MPGN is higher in HCV patients with MCs.


id: jrenhep-17
author: Kinaan, Mustafa; Yau, Hanford; Martinez, Suzanne Quinn; Kar, Pran
title: Concepts in Diabetic Nephropathy: From Pathophysiologyto Treatment
date: 2017-06-30
pages: 15
extension: .pdf
mime: application/pdf
words: 12424
sentence: 887
flesch: 44
cache: cache/jrenhep-17.pdf
txt: txt/jrenhep-17.txt
summary:
  Diabetic patients are predisposed to hyperlactemia with lac- tate levels being double than those in healthy individuals. Direct renin inhibitors like aliskiren can lower blood pres- sure and albuminuria in diabetic patients.


id: jrenhep-10
author: Salvadori, Maurizio; Tsalouchos, Aris
date: 2017-03-15
pages: 15
extension: .pdf
mime: application/pdf
words: 12603
sentence: 950
flesch: 50
cache: cache/jrenhep-10.pdf
txt: txt/jrenhep-10.txt
title:
  Novel Therapeutic Strategies Targeting Molecular Pathways of Cystogenesis in Autosomal Polycystic Kidney Disease

summary:
  Yamaguchi T, Pelling JC, Ramaswamy NT, Eppler JW, Wallace DP, Nagao S, et al. cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal regu- lated kinase pathway. Nagao et al.


# url

id: jrenhep-17
domain: us.boehringer-ingelheim.com
url:
  http://us.boehringer-ingelheim.com/news_events/press_releases/press_release_archive/2016/6-11-2016-new-study-results-show-tradjenta-linagliptin-reduces-blood-sugar-adults-type-2-diabetes-risk-kidney-impairment.html


id: jrenhep-10
domain: www.renal.org
url:
  http://www.renal.org/docs/default-source/guidelines-resources/other-guidlines/tolvaptan_in_adpkd-rawg2015_commentary-060516clean.pdf?sfvrsn=0


# ent

id: jrenhep-9
sid: 76
eid: 2
type: NORP
entity:
  http://dx.doi.org/10.4254/wjh.v7.i7.993 http://dx.doi.org/10.4254/wjh.v7.i7.993 http://dx.doi.org/10.1111/liv.12895 http://dx.doi.org/10.1053/j.ackd.2015.06.005


id: jrenhep-9
sid: 77
eid: 1
type: ORG
entity:
  http://dx.doi.org/10.4292/wjgpt.v6.i4.105 http://dx.doi.org/10.4292/wjgpt.v6.i4.105 http://dx.doi.org/10.1038/srep15501 http://dx.doi.org/10.1038/srep15501


id: jrenhep-9
sid: 77
eid: 2
type: PERSON
entity:
  http://dx.doi.org/10.1016/j.molmed.2015.08.005 http://dx.doi.org/10.1016/j.molmed.2015.08.005 http://dx.doi.org/10.1007/s00424-015-1742-0


id: jrenhep-8
sid: 26
eid: 2
type: PERSON
entity:
  mailto:gianni.testino@hsanmartino.it http://dx.doi.org/10.15586/jrenhep.2017.8 http://creativecommons.org/licenses/by/4.0 2


id: jrenhep-34
sid: 91
eid: 1
type: ORG
entity:
  https://doi.org/10.1161/circep.110.937888 https://doi.org/10.1097/00004872-200310000-00020 https://doi.org/10.1111/j.1440-1797.2004.00333.x https://doi.org/10.1111/j.1440-1797.2004.00333.x


id: jrenhep-34
sid: 181
eid: 2
type: PERSON
entity:
  https://doi.org/10.1053/ajkd.2002.32005 https://doi.org/10.1053/ajkd.2002.32005 https://doi.org/10.1159/000045387 https://doi.org/10.1177/000331970005100607 https://doi.org/10.2215/cjn.04451206


id: jrenhep-33
sid: 18
eid: 2
type: PERSON
entity:
  mailto:nicole.lioufas2@wh.org.au http://dx.doi.org/10.15586/jrenhep.2018.33 http://creativecommons.org/licenses/by/4.0 n. lioufas et al


id: jrenhep-33
sid: 193
eid: 1
type: PERSON
entity:
  http://dx.doi.org/10.1016/j.bcp.2016.04.015 http://dx.doi.org/10.1111/j.1468-1293.2012.01003.x http://dx.doi.org/10.1111/j.1468-1293.2012.01003.x


id: jrenhep-33
sid: 197
eid: 3
type: PERSON
entity:
  http://dx.doi.org/10.1093/cid/ciu730 http://dx.doi.org/10.1016/j.jhep.2012.02.010 http://dx.doi.org/10.1016/j.jhep.2012.02.010


id: jrenhep-20
sid: 231
eid: 3
type: ORG
entity:
  http://dx.doi.org/10.1056/nejm197311292892201 http://dx.doi.org/10.1056/nejm197311292892201 http://dx.doi.org/10.1002/lt.20445


id: jrenhep-2
sid: 216
eid: 1
type: ORG
entity:
  http://dx.doi.org/10.1186/cc11188 http://dx.doi.org/10.1186/cc11188 http://dx.doi.org/10.1056/nejmra0809139 http://dx.doi.org/10.1056/nejmra0809139 http://dx.doi.org/10.1056/nejm199908053410603


id: jrenhep-12
sid: 248
eid: 3
type: PERSON
entity:
  http://dx.doi.org/10.1186/cc11188 http://dx.doi.org/10.1186/cc11188 http://dx.doi.org/10.1002/hep.26185 http://dx.doi.org/10.1002/hep.26185 http://dx.doi.org/10.1016/j.jhep.2003.09.019


id: jrenhep-11
sid: 68
eid: 2
type: ORG
entity:
  whichareinvolvedinrenaltdfnephrotoxicity(30,31).aphase 2studywasperformedinhivpatientstocomparethesafetyprofile of taf


id: jrenhep-11
sid: 182
eid: 4
type: PERSON
entity:
  http://dx.doi.org/10.1002/1096-9071(200007)61:3%3c362::aid-jmv14%3e3.0.co;2-i http://dx.doi.org/10.1002/1096-9071(200007)61:3%3c362::aid-jmv14%3e3.0.co;2-i http://dx.doi.org/10.1016/j.jhep.2012.02.010 http://dx.doi.org/10.1016/j.jhep.2012.02.010 http://dx.doi.org/10.1016/j.jhep.2013.06.029 http://dx.doi.org/10.1016/j.jhep.2013.06.029


id: jrenhep-11
sid: 184
eid: 1
type: PERSON
entity:
  http://dx.doi.org/10.1016/j.japh.2016.02.013 http://dx.doi.org/10.1016/j.japh.2016.02.013 http://dx.doi.org/10.1128/aac.46.3.716-723.2002 http://dx.doi.org/10.1128/aac.46.3.716-723.2002


id: jrenhep-11
sid: 310
eid: 3
type: ORG
entity:
  http://dx.doi.org/10.1007/s10157-012-0585-7 http://dx.doi.org/10.1007/s10157-012-0585-7 http://dx.doi.org/10.1038/ki.2013.249


id: jrenhep-11
sid: 321
eid: 1
type: PERSON
entity:
  http://dx.doi.org/10.1371/journal.pone.0032445 http://dx.doi.org/10.1371/journal.pone.0032445 http://dx.doi.org/10.1093/jac/dkt265 http://dx.doi.org/10.1097/qai.0b013e31828175c9 http://dx.doi.org/10.1097/qai.0b013e31828175c9


id: jrenhep-3
sid: 295
eid: 1
type: ORG
entity:
  http://dx.doi.org/10.1016/j.ejim.2013.08.701 http://dx.doi.org/10.1371/journal.pone.0102748 http://dx.doi.org/10.1371/journal.pone.0102748 http://dx.doi.org/10.1002/jca.20232


id: jrenhep-3
sid: 295
eid: 2
type: PERSON
entity:
  http://dx.doi.org/10.1097/00004836-200301000-00016 http://dx.doi.org/10.1097/00004836-200301000-00016 http://dx.doi.org/10.1155/2012/501373 http://dx.doi.org/10.1155/2012/501373 http://dx.doi.org/10.1016/j.atherosclerosissup.2015.02.017 http://dx.doi.org/10.1016/j.atherosclerosissup.2015.02.017 http://dx.doi.org/10.1111/1744-9987.12008


id: jrenhep-15
sid: 311
eid: 1
type: ORG
entity:
  http://dx.doi.org/10.1371/journal.pone.0132119 http://dx.doi.org/10.1111/ctr.12351 http://dx.doi.org/10.1111/ctr.12351


id: jrenhep-58
sid: 36
eid: 1
type: PERSON
entity:
  http://creativecommons.org/licenses/by/4.0 http://creativecommons.org/licenses/by/4.0 evangelos c. fradelos journal


id: jrenhep-58
sid: 225
eid: 1
type: ORG
entity:
  https://doi.org/10.1159/000484115 https://doi.org/10.1159/000484115 https://doi.org/10.1007/s40273-016-0389-9


id: jrenhep-58
sid: 313
eid: 2
type: PERSON
entity:
  https://doi.org/10.1002/dat.20296 https://doi.org/10.1002/dat.20296 https://doi.org/10.1080/0886022x.2017.1398095


id: jrenhep-52
sid: 27
eid: 1
type: PERSON
entity:
  http://creativecommons.org/licenses/by/4.0 http://creativecommons.org/licenses/by/4.0 chávez-iñiguez js et al


id: jrenhep-49
sid: 283
eid: 2
type: PERSON
entity:
  https://doi.org/10.1038/nature14549 https://doi.org/10.4267/2042/62515 https://doi.org/10.4267/2042/62515 http://www.ncbi.nlm.nih.gov/pubmed/10946019 http://www.ncbi.nlm.nih.gov/pubmed/10946019


id: jrenhep-49
sid: 416
eid: 3
type: PERSON
entity:
  https://doi.org/10.1016/j.bmcl.2010.01.083 https://doi.org/10.1016/j.bmcl.2010.01.083 https://doi.org/10.1021/jm200319u https://doi.org/10.1021/jm200319u


id: jrenhep-56
sid: 31
eid: 1
type: PERSON
entity:
  http://dx.doi.org/10.15586/jrenhep.2019.56 http://creativecommons.org/licenses/by/4.0 http://creativecommons.org/licenses/by/4.0


id: jrenhep-56
sid: 237
eid: 1
type: ORG
entity:
  https://doi.org/10.1111/apt.13156 https://doi.org/10.3390/ijms19092804 https://doi.org/10.1152/japplphysiol.91397.2008 https://doi.org/10.1152/japplphysiol.91397.2008


id: jrenhep-56
sid: 359
eid: 3
type: ORG
entity:
  https://doi.org/​10.1016/j.mce.2008.12.019 https://doi.org/​10.1016/j.mce.2008.12.019 https://doi.org/10.1111/j.1365-2265.1995.tb02040.x https://doi.org/10.1111/j.1365-2265.1995.tb02040.x


id: jrenhep-56
sid: 359
eid: 4
type: PERSON
entity:
  https://doi.org/10.1016/j.jhep.2006.02.016 https://doi.org/10.1152/ajpendo.00366.​2001 https://doi.org/10.1152/ajpendo.00366.​2001 https://doi.org/10.1074/jbc.m110.159392


id: jrenhep-56
sid: 360
eid: 1
type: PERSON
entity:
  https://doi.org/10.1093/ajcn/85.5.1257 https://doi.org/10.1093/ajcn/85.5.1257 https://doi.org/10.1016/s1470-2045


id: jrenhep-56
sid: 363
eid: 1
type: FAC
entity:
  https://doi.org/10.1152/ajpgi.00322.2015 https://doi.org/10.1152/ajpgi.00322.2015 https://doi.org/10.3109/00365529009095494


id: jrenhep-56
sid: 368
eid: 1
type: PRODUCT
entity:
  https://doi.org/10.1093/jn/130.10.2413 https://doi.org/10.1093/jn/131.4.1171 https://doi.org/10.1093/jn/131.4.1171 gonzaga er et al


id: jrenhep-56
sid: 450
eid: 1
type: PERSON
entity:
  https://doi.org/10.5604/01.3001.0012.0930 https://doi.org/10.5604/01.3001.0012.0930 https://doi.org/10.1016/s0168-8278(97)80026-8


id: jrenhep-37
sid: 316
eid: 2
type: PERSON
entity:
  https://doi.org/10.1016/s0022-5347(01)63072-6 https://doi.org/10.1016/s0022-5347(01)63072-6 https://doi.org/10.1016/s0887-2171(97)90054-8 https://doi.org/10.1097/00000478-199710000-00001


id: jrenhep-37
sid: 447
eid: 1
type: ORG
entity:
  https://doi.org/10.1148/ radiology.198.3.8628873 https://doi.org/10.1016/j.rcl.2011.05.003 https://doi.org/10.1016/j.rcl.2011.05.003 https://doi.org/10.1148/radiol.2251011477 https://doi.org/10.1093/ndt/gft009 https://doi.org/10.1093/ndt/gft009 https://doi.org/10.1097/01.rvi.0000143769.79774.70 https://doi.org/10.1097/01.rvi.0000143769.79774.70 https://doi.org/10.1016/s1051-0443(98)70266-0 https://doi.org/10.1056/nejmoa063564 https://doi.org/10.1056/nejmoa063564 https://doi.org/10.1183/09031936.00076209 https://doi.org/10.1183/09031936.00076209


id: jrenhep-37
sid: 448
eid: 1
type: PERSON
entity:
  https://doi.org/10.1148/radiology.216.1.r00jl42147 https://doi.org/10.1148/radiology.216.1.r00jl42147


id: jrenhep-6
sid: 300
eid: 1
type: ORG
entity:
  http://dx.doi.org/10.1038/nature08436 http://dx.doi.org/10.1038/nature08436 http://dx.doi.org/10.1038/nature12271


id: jrenhep-6
sid: 300
eid: 2
type: GPE
entity:
  http://dx.doi.org/10.1016/j.stem.2016.05.019 http://dx.doi.org/10.1038/srep19969 http://dx.doi.org/10.1038/srep19969


id: jrenhep-6
sid: 300
eid: 3
type: ORG
entity:
  http://dx.doi.org/10.1016/j.cell.2007.11.019 http://dx.doi.org/10.1126/science.1225829 http://dx.doi.org/10.1007/s13238-015-0180-2 http://dx.doi.org/10.1007/s13238-015-0180-2


id: jrenhep-6
sid: 431
eid: 1
type: QUANTITY
entity:
  27 http://dx.doi.org/10.1073/pnas.0806522105 http://dx.doi.org/10.1073/pnas.0806522105 http://dx.doi.org/10.1016/j.stem.2008.07.021


id: jrenhep-6
sid: 438
eid: 1
type: LOC
entity:
  http://dx.doi.org/10.1038/nrm.2016.10 http://dx.doi.org/10.1038/nrm.2016.10 http://dx.doi.org/10.1038/nature.2016.20302


id: jrenhep-6
sid: 536
eid: 5
type: PRODUCT
entity:
  http://dx.doi.org/10.1007/978-3-642-30406-4_21 http://dx.doi.org/10.1007/978-3-642-30406-4_21 http://dx.doi.org/10.1172/jci43267 http://dx.doi.org/10.1007/s12015-011-9330-y http://dx.doi.org/10.1007/s12015-011-9330-y


id: jrenhep-6
sid: 540
eid: 1
type: PERSON
entity:
  http://dx.doi.org/10.1111/j.1749-6632.2009.04563.x http://dx.doi.org/10.1172/jci43122 http://dx.doi.org/10.5681/apb.2015.041


id: jrenhep-5
sid: 199
eid: 2
type: DATE
entity:
  11–19 16 http://dx.doi.org/10.1126/science.1104742 http://dx.doi.org/10.1002/hep.22507 http://dx.doi.org/10.3748/wjg.v13.i35.4725


id: jrenhep-5
sid: 337
eid: 1
type: ORG
entity:
  http://dx.doi.org/10.1152/physiolgenomics.00217.2004 http://dx.doi.org/10.1152/physiolgenomics.00217.2004 https://dx.doi.org/10.1172/jci63924 https://dx.doi.org/10.1172/jci63924


id: jrenhep-5
sid: 340
eid: 1
type: PERSON
entity:
  http://dx.doi.org/10.1038/ki.2009.21 http://dx.doi.org/10.1111/j.1365-2362.2009.02182.x http://dx.doi.org/10.1111/j.1365-2362.2009.02182.x http://dx.doi.org/10.1002/hep.20652 http://dx.doi.org/10.1002/hep.20652 http://dx.doi.org/10.1111/j.1525-139x.2008.00532.x http://dx.doi.org/10.1111/j.1525-139x.2008.00532.x http://dx.doi.org/10.1093/ndt/gfg111 http://dx.doi.org/10.1093/ndt/gfg111


id: jrenhep-5
sid: 478
eid: 1
type: PRODUCT
entity:
  http://dx.doi.org/10.1053/j.ajkd.2011.03.031 http://dx.doi.org/10.1053/j.ajkd.2011.03.031 http://dx.doi.org/10.1056/nejm196703232761202


id: jrenhep-5
sid: 482
eid: 1
type: ORG
entity:
  http://dx.doi.org/10.1161/01.cir.0000035250.66458.67 http://dx.doi.org/10.1093/ndt/gfs488 http://dx.doi.org/10.1093/ndt/gfs488 http://dx.doi.org/10.1161/01.atv.0000124892.90999.cb http://dx.doi.org/10.1161/01.atv.0000124892.90999.cb http://dx.doi.org/10.1016/j.jacc.2011.10.852 http://dx.doi.org/10.1016/j.jacc.2011.10.852


id: jrenhep-5
sid: 488
eid: 1
type: ORG
entity:
  http://dx.doi.org/10.1056/nejmoa062276 http://dx.doi.org/10.1056/nejmoa065485 http://dx.doi.org/10.1056/nejmoa065485 http://dx.doi.org/10.1056/nejmoa0907845 http://dx.doi.org/10.1681/asn.2010111133 http://dx.doi.org/10.1161/hypertensionaha.111.173690


id: jrenhep-5
sid: 589
eid: 1
type: LOC
entity:
  http://dx.doi.org/10.1097/00005344-199500252-00016 http://dx.doi.org/10.1097/00005344-199500252-00016


id: jrenhep-5
sid: 590
eid: 1
type: PERSON
entity:
  http://dx.doi.org/10.1111/j.1440-1797.2009.01203.x http://dx.doi.org/10.1111/j.1440-1797.2009.01203.x


id: jrenhep-5
sid: 594
eid: 1
type: PERSON
entity:
  http://dx.doi.org/10.1182/blood-2013-06-505792 http://dx.doi.org/10.1182/blood-2013-06-505792 http://dx.doi.org/10.1053/j.ajkd.2016.03.418 http://dx.doi.org/10.5414/cn107018


id: jrenhep-47
sid: 371
eid: 1
type: PERSON
entity:
  https://doi.org/10.1146/annurev-physiol-021014-071720 https://doi.org/10.1146/annurev-physiol-021014-071720


id: jrenhep-47
sid: 371
eid: 2
type: PERSON
entity:
  https://doi.org/10.1042/bj3480021 https://doi.org/10.1074/jbc.m203355200 https://doi.org/10.1038/srep35598 https://doi.org/10.1073/pnas.95.7.3408 https://doi.org/10.1073/pnas.95.7.3408


id: jrenhep-47
sid: 509
eid: 1
type: ORG
entity:
  https://doi.org/10.1007/s10585-011-9410-z https://doi.org/10.1007/s10585-011-9410-z https://doi.org/10.1053/j.gastro.2016.07.043 https://doi.org/10.1053/j.gastro.2016.07.043


id: jrenhep-18
sid: 277
eid: 1
type: PERSON
entity:
  http://dx.doi.org/10.1111/j.1399-3046.2008.01046.x http://dx.doi.org/10.1111/j.1399-3046.2008.01046.x


id: jrenhep-18
sid: 278
eid: 1
type: ORG
entity:
  http://dx.doi.org/10.1111/j.1600-6143.2012.04190.x http://dx.doi.org/10.1111/j.1600-6143.2012.04190.x http://dx.doi.org/10.1111/j.1600-6143.2007.01856.x


id: jrenhep-18
sid: 425
eid: 1
type: PERSON
entity:
  http://dx.doi.org/10.1002/humu.9200 http://dx.doi.org/10.1046/j.1523-1755.2001.00462.x http://dx.doi.org/10.1046/j.1523-1755.2001.00462.x http://dx.doi.org/10.1016/j.ajhg.2010.07.023


id: jrenhep-18
sid: 429
eid: 1
type: PRODUCT
entity:
  http://dx.doi.org/10.1007/s00467-006-0124-4 http://dx.doi.org/10.1097/mot.0b013e32833e35f5 http://dx.doi.org/10.1097/mot.0b013e32833e35f5


id: jrenhep-18
sid: 550
eid: 1
type: PERSON
entity:
  http://dx.doi.org/10.1097/mop.0000000000000422 http://dx.doi.org/10.1203/pdr.0b013e3180a0325f http://dx.doi.org/10.1203/pdr.0b013e3180a0325f http://dx.doi.org/10.1034/j.1399-3046.2002.02009.x


id: jrenhep-18
sid: 558
eid: 1
type: ORG
entity:
  http://dx.doi.org/10.1002/lt.22019 http://dx.doi.org/10.1016/j.ejcts.2007.03.023 http://dx.doi.org/10.1016/j.ejcts.2007.03.023


id: jrenhep-18
sid: 687
eid: 1
type: PERSON
entity:
  http://dx.doi.org/10.1016/j.transproceed.2013.10.033 http://dx.doi.org/10.1016/j.transproceed.2013.10.033 http://dx.doi.org/10.1186/1750-1172-9-47


id: jrenhep-18
sid: 687
eid: 2
type: ORG
entity:
  http://dx.doi.org/10.1111/j.1432-2277.1996.tb00993.x http://dx.doi.org/10.1111/j.1432-2277.1996.tb00993.x http://dx.doi.org/10.1023/b:boli.0000037397.39725.57


id: jrenhep-18
sid: 687
eid: 3
type: FAC
entity:
  http://dx.doi.org/10.1016/j.transproceed.2004.05.070 http://dx.doi.org/10.1016/j.transproceed.2004.05.070 http://dx.doi.org/10.1002/lt.21147 http://dx.doi.org/10.1016/j.transproceed.2011.03.003 http://dx.doi.org/10.1016/j.transproceed.2011.03.003


id: jrenhep-18
sid: 690
eid: 1
type: ORG
entity:
  http://dx.doi.org/10.1111/j.1399-3046.2011.01497.x http://dx.doi.org/10.1111/j.1399-3046.2011.01497.x http://dx.doi.org/10.1097/01.tp.0000185194.62108.a7 102


id: jrenhep-18
sid: 756
eid: 1
type: GPE
entity:
  http://dx.doi.org/10.1016/s0168-8278(97)80478-3 http://dx.doi.org/10.1016/s0168-8278(97)80478-3 http://dx.doi.org/10.1016/s0168-8278(02)00012-0 http://dx.doi.org/10.3233/trd-160007


id: jrenhep-43
sid: 376
eid: 2
type: PERSON
entity:
  https://doi.org/10.1002/1529-0131(199910)42:10%3c2204::aid-anr24%3e3.0.co;2-d https://doi.org/10.1002/1529-0131(199910)42:10%3c2204::aid-anr24%3e3.0.co;2-d https://doi.org/10.1016/j.dld.2006.06.008


id: jrenhep-43
sid: 377
eid: 1
type: PERSON
entity:
  https://doi.org/10.1111/hdi.12672 https://doi.org/10.1111/hdi.12672 https://doi.org/10.1111/j.1523-1755.2004.00649 https://doi.org/10.1111/j.1523-1755.2004.00649


id: jrenhep-43
sid: 379
eid: 1
type: ORG
entity:
  https://doi.org/10.1681/asn.2005091006 https://doi.org/10.1681/asn.2005091006 https://doi.org/10.1093/ndt/gfm205


id: jrenhep-43
sid: 382
eid: 1
type: FAC
entity:
  https://doi.org/10.1111/j.1365-2893.2012.01633.x https://doi.org/10.1111/j.1365-2893.2012.01633.x hepatitis c virus


id: jrenhep-43
sid: 526
eid: 1
type: EVENT
entity:
  https://doi.org/10.1111/j.1365-2893.2012.01633.x https://doi.org/10.1111/j.1365-2893.2012.01633.x https://doi.org/10.1002/hep.29192 https://doi.org/10.1016/j.kint.2017.03.021


id: jrenhep-43
sid: 669
eid: 1
type: ORG
entity:
  https://doi.org/10.1111/j.1399-0012.2011.01583.x https://doi.org/10.1097/tp.0b013e318225dbae https://doi.org/10.1097/tp.0b013e318225dbae


id: jrenhep-43
sid: 671
eid: 1
type: PERSON
entity:
  https://doi.org/10.2215/cjn.12571213 https://doi.org/10.1128/jcm.02831-14 https://doi.org/10.1093/ndt/gfm678


id: jrenhep-43
sid: 802
eid: 1
type: FAC
entity:
  https://doi.org/10.1002/hep.27664 https://doi.org/10.1111/j.1523-1755.2005.00080.x https://doi.org/10.1111/j.1523-1755.2005.00080.x


id: jrenhep-43
sid: 803
eid: 1
type: PERSON
entity:
  https://doi.org/10.1053/j.gastro.2010.07.009 https://doi.org/10.1111/jvh.12611 https://doi.org/10.1111/jvh.12611


id: jrenhep-43
sid: 806
eid: 1
type: PERSON
entity:
  https://doi.org/10.1111/jvh.12639 https://doi.org/10.1371/journal.pone.0194329 https://doi.org/10.1371/journal.pone.0194329 https://doi.org/10.1016/s2157-1716(18)30010-8


id: jrenhep-43
sid: 865
eid: 1
type: PERSON
entity:
  https://doi.org/10.1002/hep.29258 https://doi.org/10.1002/hep.30046 https://doi.org/10.1002/hep.30046 https://doi.org/10.1093/cid/ciy585


id: jrenhep-17
sid: 446
eid: 4
type: FAC
entity:
  http://dx.doi.org/10.2337/diacare.27.5.1047 http://dx.doi.org/10.2337/diacare.27.5.1047 http://dx.doi.org/10.1016/j.diabres.2013.11.002 http://dx.doi.org/10.2337/diacare.24.11.1936 http://dx.doi.org/10.2337/diacare.24.11.1936 https://www.usrds.org/2015/view/default.aspx


id: jrenhep-17
sid: 581
eid: 1
type: ORG
entity:
  http://dx.doi.org/10.1038/ki.2013.427 http://dx.doi.org/10.1038/ki.2013.427 http://dx.doi.org/10.2337/diacare.28.1.164 http://dx.doi.org/10.2337/diacare.28.1.164 http://dx.doi.org/10.2337/diacare.22.2.307


id: jrenhep-17
sid: 707
eid: 1
type: ORG
entity:
  http://dx.doi.org/10.2337/diacare.23.10.1478 http://dx.doi.org/10.1056/nejmoa0808431 http://dx.doi.org/10.1056/nejmoa0808431 http://dx.doi.org/10.1056/nejmoa0802987


id: jrenhep-17
sid: 718
eid: 1
type: ORG
entity:
  http://us.boehringer-ingelheim.com/news_events/press_releases/press_release_archive/2016/6-11-2016-new-study-results-show-tradjenta-linagliptin-reduces-blood-sugar-adults-type-2-diabetes-risk-kidney-impairment.html http://us.boehringer-ingelheim.com/news_events/press_releases/press_release_archive/2016/6-11-2016-new-study-results-show-tradjenta-linagliptin-reduces-blood-sugar-adults-type-2-diabetes-risk-kidney-impairment.html http://us.boehringer-ingelheim.com/news_events/press_releases/press_release_archive/2016/6-11-2016-new-study-results-show-tradjenta-linagliptin-reduces-blood-sugar-adults-type-2-diabetes-risk-kidney-impairment.html http://us.boehringer-ingelheim.com/news_events/press_releases/press_release_archive/2016/6-11-2016-new-study-results-show-tradjenta-linagliptin-reduces-blood-sugar-adults-type-2-diabetes-risk-kidney-impairment.html


id: jrenhep-17
sid: 842
eid: 3
type: GPE
entity:
  http://dx.doi.org/10.1016/j.jdiacomp.2016.09.016 http://dx.doi.org/10.1016/j.atherosclerosis.2011.12.039 http://dx.doi.org/10.1016/j.metabol.2012.03.002 http://dx.doi.org/10.1016/j.metabol.2012.03.002


id: jrenhep-17
sid: 850
eid: 1
type: ORG
entity:
  http://dx.doi.org/10.1136/bmj.f360 http://dx.doi.org/10.1056/nejmoa0801317 http://dx.doi.org/10.1056/nejmoa1303154 http://dx.doi.org/10.1056/nejmoa1208799 http://dx.doi.org/10.1056/nejmoa1208799 http://dx.doi.org/10.1038/ki.1992.139


id: jrenhep-10
sid: 339
eid: 6
type: ORG
entity:
  http://dx.doi.org/10.1006/bbrc.2001.4554 http://dx.doi.org/10.1074/jbc.m504359200 https://dx.doi.org/10.1016/j.trsl.2014.11.003 https://dx.doi.org/10.1016/j.trsl.2014.11.003 http://dx.doi.org/10.1517/13543781003588491


id: jrenhep-10
sid: 462
eid: 1
type: LOC
entity:
  http://dx.doi.org/10.1016/j.yjmcc.2013.01.015 http://dx.doi.org/10.1016/j.yjmcc.2013.01.015 http://dx.doi.org/10.1046/j.1523-1755.2003.00185.x http://dx.doi.org/10.1046/j.1523-1755.2003.00185.x


id: jrenhep-10
sid: 468
eid: 1
type: ORG
entity:
  http://dx.doi.org/10.1073/pnas.1103816108 http://dx.doi.org/10.1152/ajprenal.00419.2010 http://dx.doi.org/10.1152/ajprenal.00419.2010


id: jrenhep-10
sid: 602
eid: 1
type: ORG
entity:
  http://dx.doi.org/10.1038/ki.2011.119 http://dx.doi.org/10.1053/j.ajkd.2014.11.010 http://dx.doi.org/10.1038/ki.2013.285


id: jrenhep-10
sid: 607
eid: 1
type: PERSON
entity:
  http://dx.doi.org/10.1111/j.1523-1755.2004.00953.x http://dx.doi.org/10.1016/j.regpep.2003.12.015 65


id: jrenhep-10
sid: 871
eid: 1
type: ORG
entity:
  http://dx.doi.org/10.1093/ndt/gfs264 http://dx.doi.org/10.2215/cjn.02650313 http://dx.doi.org/10.2215/cjn.02650313 http://dx.doi.org/10.1016/j.drudis.2015.05.006


id: jrenhep-10
sid: 872
eid: 1
type: PERSON
entity:
  http://dx.doi.org/10.1074/jbc.m405079200 http://dx.doi.org/10.1074/jbc.m405079200 http://dx.doi.org/10.1152/ajpcell.00163.2010


id: jrenhep-10
sid: 995
eid: 2
type: PERSON
entity:
  http://dx.doi.org/10.1152/ajprenal.00460.2010 http://dx.doi.org/10.1093/hmg/11.15.1731 http://doi.org/10.1042/cs20100113


